Phase II study of everolimus in metastatic urothelial cancer-Reference-Cited by-同舟云学术

Phase II study of everolimus in metastatic urothelial cancer

Published:2013-04-03 Issue:4 Volume:112 Page:462-470
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Milowsky Matthew I.,Iyer Gopa,Regazzi Ashley M.¹,Al-Ahmadie Hikmat²,Gerst Scott R.³,Ostrovnaya Irina⁴,Gellert Lan L.²,Kaplan Rana,Garcia-Grossman Ilana R.¹,Pendse Deepa¹,Balar Arjun V.,Flaherty Anne Marie¹,Trout Alisa¹,Solit David B.,Bajorin Dean F.

Affiliation:

1. Genitourinary Oncology Service; Division of Solid Tumor Oncology; Department of Medicine; Memorial Sloan-Kettering Cancer Center; New York; NY; USA

2. Department of Pathology; Memorial Sloan-Kettering Cancer Center; New York; NY; USA

3. Department of Radiology; Memorial Sloan-Kettering Cancer Center; New York; NY; USA

4. Department of Epidemiology and Biostatistics; Memorial Sloan-Kettering Cancer Center; New York; NY; USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11720.x/fullpdf

Reference30 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;Maase;J Clin Oncol,2000

3. Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting;Gallagher;Cancer,2008

4. Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract;Bellmunt;J Clin Oncol,2009

5. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Neoadjuvant Chemotherapy in Advanced Bladder Cancer;annals of urologic oncology;2024-08-20

2. Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance;Urologic Oncology: Seminars and Original Investigations;2024-07

3. Landscape of targeted therapies for advanced urothelial carcinoma;Exploration of Targeted Anti-tumor Therapy;2024-06-21

4. Proteomic analysis of the urothelial cancer landscape;Nature Communications;2024-05-27

5. Bladder Cancer and the Urinary Microbiome—New Insights and Future Directions: A Review;Clinical Genitourinary Cancer;2024-04